Overview of immunology of oral squamous cell carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27829737)

Published in J Pharm Bioallied Sci on October 01, 2016

Authors

Anisha Cynthia Sathiyasekar1, Pavithra Chandrasekar1, Arul Pakash1, K U Goma Kumar1, M S Jaishlal1

Author Affiliations

1: Department of Oral and Maxillofacial Pathology, Rajas Dental College and Hospital, Tirunelveli, Tamil Nadu, India.

Articles cited by this

Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38

Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77

Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36

Mitogenic effect of phytohaemagglutinin at different ages. Nature (1967) 2.82

Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br J Cancer (1976) 1.94

Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation (1972) 1.80

IMMUNOLOGICAL DEFECT IN AGED POPULATION AND ITS RELATIONSHIP TO CANCER. Cancer (1965) 1.77

Distribution of cells binding erythrocyte-antibody (EA) complexes in human lymphoid populations. Scand J Immunol (1976) 1.53

Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet (1974) 1.48

Immunological surveillance in neoplasia. Transplant Rev (1971) 1.44

Deficient IgA antibody responses to arsanilic acid bovine serum albumin (BSA) in neonatally thymectomized rabbits. J Immunol (1971) 1.43

T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40

Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients. Int J Cancer (1975) 1.35

Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer (1973) 1.34

alpha1-Antitrypsin is an effector of immunological stasis. Nature (1978) 1.25

In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis. Am J Dig Dis (1974) 1.24

Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child (1967) 1.19

Immunologic abnormalities in head and neck cancer. Am J Surg (1974) 1.17

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology. Cancer (1973) 1.16

Risk factors associated with nasopharyngeal carcinoma. N Engl J Med (1976) 1.12

The oncogenic activity of the polyoma virus in thymectomized rats. Life Sci (1963) 1.11

Impaired delayed hypersensitivity in an aging population. Association with antinuclear reactivity and rheumatoid factor. JAMA (1968) 1.07

Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma. Int J Cancer (1976) 1.02

Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers. Cancer Res (1974) 1.00

Comparison of immune derangements in patients with different malignancies. Cancer (1980) 1.00

HL-A antigenic loss in malignant transformation. J Natl Cancer Inst (1971) 0.97

The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96

Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer. Cancer Res (1977) 0.94

Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy. AJR Am J Roentgenol (1976) 0.93

Serum beta 2 microglobulin in oral malignancy and premalignancy. J Oral Pathol (1981) 0.91

Suppression of cellular immunity by anesthesia and operation. J Surg Res (1977) 0.89

Correlation of immune reactivity and clinical status in cancer. Ann Clin Lab Sci (1974) 0.88

Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival. Cancer (1975) 0.86

Nutritional status and general immune competence in patients with head and neck cancer. J R Soc Med (1981) 0.86

A tuberculin survey of 1285 adults with special reference to the elderly. Lancet (1957) 0.85

Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens. J Natl Cancer Inst (1976) 0.85

Immunologic assessment of regional lymph node histology in relation to survival in head and neck carcinoma. Cancer (1976) 0.85

Serum glycoproteins in head and neck squamous carcinoma: correlations with tumor extent, clinical tumor stage, and T-cell levels during chemotherapy. Am J Surg (1979) 0.82

Lymph node metastases in oral carcinoma. A correlation of histopathology with survival. Plast Reconstr Surg (1974) 0.82

Effect of thymosin in vitro on T cell levels during radiation therapy: correlations with radiation portal and initial T cell levels. Cancer (1977) 0.81

Attempt at evaluation of defensive activity of lymph nodes on the basis of microscopic and clinical studies in cases of laryngeal cancer. Pol Med J (1971) 0.79

Aging, immunity, and malignancy. Geriatrics (1970) 0.78

Fluorescent antibody detection of CEA in oral squamous carcinoma. J Oral Med (1979) 0.77

Epstein-Barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer. J Surg Oncol (1978) 0.76

Plasma cells and immunoglobulin-synthesis in oral precancer and cancer. Correlation with dysplasia, cancer differentiation, radio- and chemotherapy. Virchows Arch A Pathol Anat Histol (1979) 0.76

An immune enzymatic assay for purified tumour associated antigen of herpes simplex virus. Cell Mol Biol Incl Cyto Enzymol (1979) 0.76

Correlation of serum immune-reactive proteins with clinical tumor stage in patients with squamous carcinoma of the head and neck and nasopharyngeal carcinoma. Surg Forum (1979) 0.76

Thymic function and carcinogenesis. Prog Exp Tumor Res (1967) 0.76

Immunosuppression and cancer. Importance in head and neck surgery. Arch Otolaryngol (1975) 0.76

Immunity suppression by bleomycin-methotrexate combined treatment in patients with epidermoid carcinoma of the oral cavity. J Maxillofac Surg (1974) 0.76

Defective suppressor cell activity in cancer patients: a defect in immune regulation. Cancer (1981) 0.76

The role of histopathology in diagnosis and prognosis of oral squamous cell carcinoma. Proc R Soc Med (1976) 0.76

Lymphocyte sequestration: its possible role in tumor immunity. Transplant Proc (1973) 0.76

Histocompatibility antigens and solid malignant neoplasms. Arch Surg (1975) 0.76

Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer. Cancer Res (1977) 0.76

The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract. J Surg Oncol (1978) 0.76